Estrogen receptor α (ERα), a key effector in breast cancer progression, was decreased approximately 0.5-fold (p < 0.001) and 0.2-fold (p < 0.001) in BT-474 and MCF-7 cells, respectively (Figure 2F). This evidence concerns the gene ESR1 and breast carcinoma.